Table 3. GRADE quality assessment of Comparison 2: comparing clomiphene citrate, metformin plus LC versus clomiphene citrate, metformin plus placebo.
Certainty assessment | Number of patients | Effect | Certainty | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Total study | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | LC +CC + MTF | CC + MTF + placebo | Relative (95% CI) | Absolute (95% CI) | |
Outcome: Clinical pregnancy rate | ||||||||||
1 RCT | not serious | not serious | not serious | seriousa | none | 39/138 (28.3%) | 9/136 (6.6%) | RR 4.27 (2.15 to 8.47) | 216 more per 1,000 (from 76 more to 494 more) | MODERATE |
Outcome: Ovulation rate | ||||||||||
1 RCT | not serious | not serious | not serious | seriousa | none | 48/138 (34.8%) | 15/136 (11.0%) | RR 3.15 (1.86 to 5.35) | 237 more per 1,000 (from 95 more to 480 more) | MODERATE |
Outcome: BMI | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 138 | 136 | – | MD 1.1 higher (0.32 higher to 1.88 higher) | MODERATE |
Outcome: Serum FPG | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 138 | 136 | – | MD 5.1 lower (6.25 lower to 3.95 lower) | MODERATE |
Outcome: Serum LDL | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 138 | 136 | – | MD 25 lower (27.93 lower to 22.07 lower) | MODERATE |
Outcome: Serum total cholesterol | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 138 | 136 | – | MD 21 lower (24.14 lower to 17.86 lower) | MODERATE |
Outcome: Serum HDL | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 138 | 136 | – | MD 15.5 higher (12.42 higher to 18.58 higher) | MODERATE |
Outcome: Serum triglyceride | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 138 | 136 | – | MD 9 lower (11.46 lower to 6.54 lower) | MODERATE |
Outcome: serum FSH | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 138 | 136 | – | MD 0.63 lower (0.92 lower to 0.34 lower) | MODERATE |
Outcome: serum LH | ||||||||||
1 RCT | not serious | not serious | not serious | seriousb | none | 138 | 136 | – | MD 2.36 lower (3.04 lower to 1.68 lower) | MODERATE |
Notes.
- CI
- Confidence interval
- RR
- Risk ratio
- MD
- Mean difference
- RCT
- Randomized controlled trial
- GRADE
- Working Group grades of evidence (GDT, 2022)
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.
Explanations
number of events <400.
number of participants <400.